跳至主要内容
临床试验/NCT06344910
NCT06344910招募中不适用

PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2 个研究点 分布在 1 个国家目标入组 900 人开始时间: 2024年5月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
900
试验地点
2
主要终点
Use of guideline-directed medical therapy (GDMT)

研究概览

简要总结

This is a prospective cohort study, where the investigators aim to investigate the effect of implementation of an electronic nudge alerting clinicians to the prescription of the 4 key pharmacological classes for the treatment of patients with heart failure and reduced ejection fraction (HFrEF) at the outpatient clinic in the Netherlands.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Treatment for HFrEF at the outpatient clinic cardiology.
  • Documented reduced ejection fraction of <40% based on cardiac ultrasound or cardiac magnetic resonance imaging.

排除标准

  • Opt-out for the use of routine clinical data for research purposes

结局指标

主要结局

Use of guideline-directed medical therapy (GDMT)

时间窗: 30 days (primary), 6 months (secondary)

Using all therapies according to ESC guidelines

次要结局

  • Hospitalisation for Heart Failure(6 months, 1 year)
  • renal events (>30% serum creatinine increase, hospitalization for acute kidney injury, development of end-stage kidney disease)(30 days, 6 months, 1 year)
  • All-cause mortality(1 year)
  • other major cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, non-fatal stroke)(6 months, 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Folkert W. Asselbergs

Principal Investigator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

研究点 (2)

Loading locations...

相似试验